CD4 and neoplasm: Additionally, activation of PD-1 in naïve CD4+ T cells induces their conversion to immunosuppressive CD4+ FoxP3+ T regulatory cells (Tregs) which, in a juxtracrine and paracrine manner, inhibit anti-tumour immune responses.